CKSBH - B-362 OXYGEN SCAVENGER
- MSDS: CKSBH
- Manufacturer: WATER ENGINEERING SERVICES INC
- Product Name: B-362 OXYGEN SCAVENGER
- National Stock Number: -
Product Identification
Product ID:B-362 OXYGEN SCAVENGER
MSDS Date:04/06/1999
FSC:NIIN:Submitter:F BT
Status Code:A
MSDS Number: CKSBH
Responsible Party
PHOENIX, AZ 85004
US
Emergency Phone: 800-424-9300
Info Phone: 602-252-5298
Cage: 0ZVQ6
Contractor
Telephone: 602-252-5298
Cage: 0ZVQ6
Ingredients
POTASSIUM HYDROXIDE
CAS: 1310-58-3
RTECS: TT2100000
OSHA PEL 2 MG/M3
EPA Report Quantity: 1000 LBS
DOT Report Quantity: 1000 LBS
SODIUM BISULFITE
CAS: 7631-90-5
RTECS: VZ2000000
OSHA PEL 5 MG/M3
ACGIH TLV: 5 MG/M3
EPA Report Quantity: 5000 LBS
DOT Report Quantity: 5000 LBS
WATER AND OTHER COMPONENTS
Fraction By Weight: BALANCE
Hazards
LD50 LC50 Mixture:POT. HYD.ORAL,RAL=273MG/KG
Routes of Entry: Inhalation:YES Skin:YES Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:TARGET ORGANS: SKIN, EYES. INHALATION:
IRRITATE NOSE, THROAT, RESPIRATORY SYSTEM, COUGHING, SNEEZING,
FLUSHING, HEADACHE. PROLONGED INHALATION MAY CAUSE DIFFICULTY IN
BREATHING. INDIVIDUALS SENSITIVE TO SULFITES MAY EXPERIENCE
WHEEZING, ASTHMA AND ANAPHYLACTIC REACTIONS. EYES: IRRITATION AND
WATERING. SKIN: IRRITATION AND REDNESS, DERMATITIS. INGESTION: NOT
ANTICIPATED. BRONCHOSPASM IRRITATION, VO MITING, CENTRAL NERVOUS
SYSTEM STIMULATION, LOW BLOOD PRESSURE, CARDIOVASCULAR COLLAPSE,
FLUSHING, RASH, IRREGULAR HEARTBEAT, ANAPHYLACTIC REACTIONS.
Explanation of Carcinogenicity:SODIUM BISULFITE: LD50 (ORAL, RAT) =
2G/KG ; IARC-3 COMPOUND ( NOT CLASSIFIABLE AS A HUMAN CARCINOGEN.
ACGIH A4 COMPOUND.
Effects of Overexposure:INHALATION: IRRITATE NOSE, THROAT, RESPIRATORY
SYSTEM, COUGHING, SNEEZING, FLUSHING, HEADACHE, WHEEZING, ASTHMA
AND ANAPHYLACTIC REACTIONS. EYES AND SKIN IRRITATION, DERMATITIS.
INGESTION:BRONCHOSPASM IRRITATION, VOMITING, CENTRAL NERVOUS
SYSTEM STIMULATION, LOW BLOOD PRESSURE, CARDIOVASCULAR COLLAPSE,
FLUSHING, RASH, IRREGULAR HEARTBEAT, ANAPHYLACTIC REACTIONS.
Medical Cond Aggravated by Exposure:PRE-EXSISTING DERMATITIS, OTHER
SKIN CONDITIONS, ASTHMA, AN OTHER REPIRATORY CONDITIONS MAY BE
AGGRAVATED BY OVEREXPOSURE TO THIS PRODUCT
First Aid
First Aid:SKIN: WASH WITH SOAP AND WATER FOR A MINIMUM OF 15
MIN.REMOVE CONTAMINATED CLOTHING AND WASH BEFORE REUSE. EYE: FLUSH
W/ WATER FOR MINIMUM 15 MINS. INHALATION: REMOVE TO FRESH AIR.
APPLY CPR IF NECE SSARY.INGESTION: CALL PHYSICIAN OR POISON CONTROL
CENTER. IF PROFESSIONAL ADVICE IS NOT AVAILABLE , DO NOT INDUCE
VOMITING. DRINK MILK, EGG WHITE OR LARGE QUANTITIES OF WATER. NEVER
GIVE ANYTHING BY M OUTH TO AN UNCONSCIOUS PERSON. OBTAIN MEDICAL
ATTENTION IN ALL CASES.
Fire Fighting
Flash Point:NON-FLAMMABLE
Extinguishing Media:DRY CHEMICAL, FOAM, CARBON DIOXIDE, WATER SPRAY,
HALON, AND ANY CLASS
Fire Fighting Procedures:WEAR SELF CONTAINED BREATHING APPARATUS &
PROTECTIVE CLOTHING. MOVE CONTAINERS FROM FIRE AREA IF POSSIBLE.
PREVENT RUNOFF WATER FROM ENTERING STORM DRAINS, BODIES OF WATER,
OR OTHER ENVIRONMENTALLY SE NSITIVE AREAS. RINSE CONTAMINATED
EQUIPMENT WITH SOAPY WATER BEFORE RETURNING TO SERVICE
Unusual Fire/Explosion Hazard:MAY DECOMPOSE AND PRODUCE CAUSTIC VAPORS
AND TOXIC GASES (E.G. POTASSIUM, SODIUM, AND SULFUR OXIDES). SODIUM
BISULFATE IS AN ALLERGEN.SUBSEQUENT EXPOSURE TO VERY SMALL AMOUNTS
MAY CAUSE ALLERGIC REACT ION.
Accidental Release
Spill Release Procedures:SMALL: STANDARD ABSORBANT LARGE: CLEAR
AFFECTED AREAS, PROTECT PEOPLE, RESPOND W/ TRAINED PERSONNEL. LEVEL
C PROTECTION. ABSORB SPILL W/POLYPADS OR OTHER SUITABLE ABSROBANT
MATERIALS.RINSE AREA W/SOAP & WATER SOLUTION AND FOLLOW WITH A
WATER RINSE.CLOSE OFF SEWERS AND TAKE OTHER MEASURES TO PROTECT
HUMAN HEALTH & ENVIRONMENT. DECONTAMINATE AREA THOROUGHLY.
Handling
Handling and Storage Precautions:OPEN CONTAINERS SLOWLY ON STABLE
SURFACE.EMPTY CONTAINER MAY CONTAIN RESIDUE, HANDLE W/CARE. STORE
IN COOL, DRY AREA, AWAY FROM DIRECT SUNLIGHT/HEAT/FREEZING. STORE
IN SECONDARY CONTAINERS OR DIKED AR EA, AS APPROPRIATE. KEEP
CONTAINER CLOSED WHEN NOT IN USE.
Other Precautions:INSPECT INCOMING CONTAINERS BEFORE STORAGE FOR PROPER
LABEL OR DAMAGE.
Exposure Controls
Respiratory Protection:NOT REQUIRED UNDER NORMAL CONDITIONS. IF NEEDED
USE ONLY PROTECTION AUTHORIZED IN US FEDERAL OSHA STANDARD. USE
SUPPLIED AIR RESPIRATION PROTECTION IF OXYGEN LEVELS ARE BELOW
19.5% OR ARE UNKNOWN.
Ventilation:ADEQUATE VENTILATION TO ENSURE EXPOSURE LEVELS ARE
MAINTAINED.
Protective Gloves:NEOPRENE, NITRILE RUBBER, OR BUTYL RUBBER.
Eye Protection:SPLASH GOGGLES OR SAFETY GLASSES.
Other Protective Equipment:EMERGENCY EYE WASH AND SHOWER IN WORK AREA.
APRON OR OTHER IMPERMEABLE GARMENT.
Work Hygienic Practices:AVOID GETTING PRODUCT ON/IN YOU. WASH
THOROUGHLY AFTER HANDLING. DO NOT EAT, DRINK, SMOKE, APPLY
COSMETICS WHILE HANDLING. AVOID BREATHING VAPORS. USE IN WELL
VENTILATED AREA.
Supplemental Safety and Health
FOR SPILLS- LEVEL C PERSONAL PROTECTIVE EQUIPMENT: TRIPLE-GLOVES
(RUBBER AND NITRILE OVER LATEX), CHEMICAL RESISTANT SUIT AND BOOTS,
HARD HAT, AIR-PURIFYING RESPIRATOR WITH ORGANIC VAPOR CARTRIDGE. SE
LF CONTAINED BREATHING APPARATUS MUST BE SELECTED IF RELEASES OCCUR
IN WHICH OXYGEN LEVEL IS BELOW 19.5%.
Chemical Properties
Boiling Pt:=150.C, 302.F
Spec Gravity:1.280
pH:7.0-7.5
Solubility in Water:COMPLETE
Appearance and Odor:LIGHT PURPLE LIQUID WITH STRONG SULFUR ODOR
Stability
Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZERS, ACIDS, WATER-REACTIVE MATERIALS
Stability Condition to Avoid:EXTREME TEMPERTURES, INCOMBATIBLE
CHEMICALS
Hazardous Decomposition Products:POTASSIUM, SODIUM, SULFUR OXIDES
Disposal
Waste Disposal Methods:PLACE ALL SPILL RESIDUE IN APPROPRIATE CONTAINER
AND SEAL. DISPOSE OF IN ACCORDANCE W/LOCAL, STATE & FEDERAL
REGULATIONS.
Toxicology
Toxicological Information:PRODUCT IRRITATING TO CONTAMINATED TISSUE,
PROLONGED EXPOSURE. SODIUM BISULFITE IS AN ALLERGEN. POTASSIUM
HYDROXIDE:SKIN IRRITANT(HUMAN)=50MG/24HRS-SEVERE. EYE
IRRITANT(RABBIT)=1MG/24HRS/RINSE-MODERA TE. SODIUM BISULFITE:TDLO
(INTRAPERTIONEAL,RAT)=4381MG/KG/21DAYS/INTERMITTENT;LIVER CHANGES.
BLOOD:CHANGES IN SERUM COMPOSITION; BIOCHEMICAL: ENZYME INHIBITION,
INDUCTION, OR CHANGE IN BLOOD TISSUE LE VELS.TDLO(INTRAVENOUS,
RABBIT)=450 MG/KG/3WEEKS/INTERMITTENT; VASCULAR: THROMBOSIS DISTANT
FROM INJECTION SITE; SKIN AND APPENDAGES. DERMATITIS.NOT REPORTED
TO PRODUCE MUTAGENIC/EMBRYOTOXIC/ TERATOGEN IC/ REPRODUCTIVE
TOXICITY IN HUMANS.
Other Information
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ecology
Ecological:PRODUCT WILL REACT WITH OTHER SUBSTANCES OR BE DEGRADED OVER
TIME INTO OTHER INORGANIC COMPOUNDS. POTASSIUM HYDROXIDE: WATER
SOLUBILITY = 111 G/ 100 ML (25C). PERSISTENCE: NATURAL CARBON
DIOXIDE WILL NEUTRALIZE VERY SLOWLY. MAJOR SPECIES THREATENED:
ALL. HARMFUL OR FATAL TO CONTAMINATED PLANT, AQUATIC PLANT, AND
ANIMAL LIFE (ESPECIALLY IF LARGE QUANTITIES ARE RELEASED).
POTASSIUM HYDROXIDE: TLM (M OSQUITO FISH)= 80 PPM/ 24 HOURS/ FRESH
WATER.
Transport
Transport Information:NOT A MARINE POLLUTANT
Regulatory
SARA Title III Information:304: POTASSIUM HYDROXIDE, SODIUM BISULFITE.
SARA PLANNING QUANTITY: NO SPECIFIC, TPQ DEFAULT IS 10,000 LB.
Federal Regulatory Information:CERCLA RQ: POTASSIUM HYDROXIDE = 1000
LBS. TSCA INVENTORY STATUS: LISTED IN TSCA. SODIUM BISULFITE IS
LISTED AS HAZARDOUS SUBSTANCE UNDER SECTION 311 OF THE FEDERAL
WATER POLLUTION ACT AND IS REGULATE D BY THE CLEAN WATER ACT
AMENDMENTS OF 1977 AND 1978.
State Regulatory Information:POTASSIUM HYDROXIDE AND SODIUM BISULFITE:
ALASKA, CALIFORNIA, FLORIDA, ILLINOIS, MASSACHUSETTS, MISSOURI, NEW
JERSEY, NORTH DAKOTA, PENNSYLVANIA, RHODE ISLAND. SODIUM BISULFITE:
MINNESOTA.